Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy
Andrés, E.; Goichot, B.; Kurtz, J.E.; Dufour, P.; Imler, M.; Schlienger, J.L.
Presse Medicale 28(2): 75
1999
ISSN/ISBN: 0755-4982 PMID: 9989298 Document Number: 511251
Document emailed within 1 workday
Related Documents
Klaassen, D.J.; Rapp, E.F.; Hirte, W.E. 1976: Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women Cancer Treatment Reports 60(3): 251-253Ciatto, S.; Pacini, P.; Confortini, M.; Massimo, V. 1994: Reliability of immunocytochemical assay of estrogen receptors on breast cancer aspirates as a predictor of clinical response to hormone therapy Acta Cytologica 38(4): 666-667
Innocenzi, A.; Obialero, M. 1976: Combined therapy in the treatment of breast cancer with report of an unusual case of carcinomatous mastitis in an elderly woman Minerva Chirurgica 31(19): 1071-1080
Bredin, C.; Terris, Bît.; Sogni, P.; Podevin, P. 2005: Carcinomatous meningitis as a rare presentation of gastric cancer Presse Medicale 34(7): 509-510
Darne, R.D. 1972: Secondary carcinomatous deposits in the skeletal muscles in association with non-metastatic carcinomatous neuromyopathy Indian Journal of Cancer 9(3): 251-253
Kaya, S.; Aktas, B.; Tanrikulu Sismek, E.; Akif Ozturk, M.; Dede, F.; Kaya, H.; Ugurlu, U.; Ozgen, Z.; Koca, S.; Halil, S.; Hasanov, R.; Alan, O.; Akgul Babacan, N.; Ercelep, O.; Dane, F.; Gumus, M.; Yumuk, F. 2017: Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 22(5): 1191-1198
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Ersbøll, J. 2004: Breast cancer, mammography screening and hormone therapy Ugeskrift for Laeger 166(36): 3113-3114
Levgur, M. 2004: Hormone therapy for women after breast cancer: a review Journal of Reproductive Medicine 49(7): 510-526
Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J. 1986: Hormone therapy of metastasizing breast cancer with tamoxifen Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530
Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Hoffman, N.R. 1979: Liver injury secondary to radiation therapy for breast cancer Minnesota Medicine 62(11): 778-780
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274